InspireMD Inc. (NSPR) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Inspiremd Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.177 Good morning and welcome to InspireMD's fourth quarter and full year 2025 earnings 00:00:05.177 -- 00:00:09.462 conference call. Currently, all participants are in listen-only mode. 00:00:09.462 -- 00:00:14.148 We will facilitate a question-and-answer session towards the end of today's call. 00:00:14.148 -- 00:00:17.431 This call is being recorded for replay purposes. 00:00:17.431 -- 00:00:21.556 I would now like to turn the call over to Webb Campbell from Gilmour & Group for introductory 00:00:21.556 -- 00:00:23.556 disclosures. 00:00:25.208 -- 00:00:29.772 Thank you for joining us for the InspireMD fourth quarter and full year 2025 conference 00:00:29.772 -- 00:00:35.277 call. Joining us today from InspireMD are Marvin Flawson, Chief Executive Officer, 00:00:35.277 -- 00:00:40.242 and Mike Lawless, Chief Financial Officer, and Shane Gleason, Chief Commercial Officer. 00:00:40.242 -- 00:00:44.365 During this call, management will make forward-looking statements, which are based upon 00:00:44.365 -- 00:00:49.430 management's current expectations, beliefs, and projections, many of which, by their 00:00:49.430 -- 00:00:54.514 nature, are inherently uncertain. These forward-looking statements involve risks and 00:00:54.514 -- 00:00:59.516 uncertainties that may cause actual results to differ materially from those expressed 00:00:59.516 -- 00:01:04.521 in such forward-looking statements. For more information about these risks, please refer 00:01:04.521 -- 00:01:10.006 to the risk factors described in InspireMD's most recently filed periodic 00:01:10.006 -- 00:01:15.292 report on Form 10-K and Form 10-Q, or any updates in its current 00:01:15.292 -- 00:01:20.837 report on Form 8-K filed with the U.S. Securities and Exchange Commission 0...